5328512025-01-012025-03-315328512025-03-315328512024-03-315328512024-04-012025-03-315328512025-01-012025-03-31in-capmkt:OtherExpenses1Member5328512024-04-012025-03-31in-capmkt:OtherExpenses1Member5328512025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15328512025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25328512025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss35328512025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss45328512024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15328512024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25328512024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss35328512024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss45328512025-01-012025-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15328512024-04-012025-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15328512025-01-012025-03-31AuditorDomain15328512025-01-012025-03-31AuditorDomain2iso4217:INRxbrli:pureiso4217:INRxbrli:shares532851INSECTICIDNAINE070I01018Insecticides (India) LimitedMain BoardEquity2024-04-012025-03-312025-05-282025-03-24INRLakhsQuarterlyFourth quarterSingle segmentAgro-Chemicals2025-05-2814:00:002025-05-2815:30:00trueCash Flow IndirectDeclaration of unmodified opinion2025-01-012025-03-31AuditedConsolidated35892050002855500036177600003263784000121955000-1110114000286347000214090007170400074248400033975690002201910000220191000122613000-4129100081322000013886900000042000138911000-7413000131498000000029097800004.774.77004.774.770001. The above Audited Consolidated Financial Results have been published in accordance with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The above results have been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on May 28, 2025. The auditors of the company have carried out the audit of the same. The Audit Report along with Financial Results for the quarter and year ended March 31, 2025 are available on the Stock Exchanges website at www.bseindia.com, www.nseindia.com and on the Company website www.insecticidesindia.com. 2. The above Audited Financial Results have been prepared in accordance with the Indian Accounting Standard (Ind AS), the provisions of the Companies Act, 2013 (the Act), as applicable and guidelines issued by the Securities and Exchange Board of India (SEBI). The Ind AS are prescribed under Section 133 of the Act read with Rule 3 of the Companies (Indian Accounting Standards) Rules, 2015 and subsequent amendments thereto. 3. The Company is in the business of manufacturing and distribution of Agro-Chemicals and accordingly has one business segment viz Agro-Chemicals comprising of Technical & Formulation. 5. The Board of Directors of Insecticides (India) Limited at its meeting held on August 09, 2024 had approved the dissolution/ liquidation of its wholly owned subsidiary IIL Overseas DMCC, Dubai. Accordingly, IIL Overseas DMCC has filed the application for windup / dissolution with DMCCA (Office of the Registrar of Companies of Dubai Multi Commodities Centre Authority) for which approval is yet to be received as of March 31, 2025. 6. The figures of the last quarter are the balancing figures between audited figures in respect of the full financial year up to 31 March 2025 and the unaudited published year-to-date figures up to 31 December 2024 being the date of the end of the third quarter of the financial year which were subjected to a limited review. 2024-04-012025-03-31AuditedConsolidated19999496000699550002006945100013483766000751127000-643678000138709700068645000291534000280901100018147502000192194900001921949000559147000-516390005075080000141444100000057450001420186000-134170001406769000000029097800001055496000048.3848.380048.3848.38000other expenses742484000other expenses280901100023119880001561093000299150000863400004985300001152370008221800000267600001089780001527100045210200047307770008862454000957450003853165000559270000118110002501000802470004602739000078548600014250679000001898145600029097800010554960000108459380000108459380002347240000002646000026118400055026000443080000036051800076149900022683600048506080005077444000493231000633217400013064380004838200088006000077750000000081355180001898145600068645000-788627000-939804000-1062000398400000-3072000-7147400009105410000-12284000002915340000264940000-295220000022830002355100000075824000000-56935700013525920000004180230000934569000000000002618700037289000023986000804850000000000000-231000000022170002355100000-377203000000061880200000029208400013311200022041000591960006985500000-610922000-535560000-53556000612826000559270000Changes in fair value of FVTOCI equity instruments3126000Remeasurement of net defined benefit plans-13577000Share of Other comprehensive income of joint venture accounted for using equity method466000Income tax relating to these items2572000-7413000Changes in fair value of FVTOCI equity instruments-3071000Remeasurement of net defined benefit plans-13952000Share of Other comprehensive income of joint venture accounted for using equity method-826000Income tax relating to these items4435000-1341400000Exchange differences in translating the financial statements of foreign operations00Exchange differences in translating the financial statements of foreign operations-3000-300000-7413000-13417000AuditedtrueS S Kothari Mehta & Co., LLPtrue2025-08-31Devesh Parekh & Cotrue2028-02-29